Cargando…

Effects of Recombinant Human Erythropoietin on Resistance Artery Endothelial Function in Stage 4 Chronic Kidney Disease

BACKGROUND: Recent studies have raised concern about the safety of erythropoiesis‐stimulating agents because of evidence of increased risk of hypertension and cardiovascular morbidity and mortality in chronic kidney disease (CKD) patients. In the present study, we investigated the effects of recombi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Briet, Marie, Barhoumi, Tlili, Mian, Muhammad Oneeb Rehman, Sierra, Cristina, Boutouyrie, Pierre, Davidman, Michael, Bercovitch, David, Nessim, Sharon J., Frisch, Gershon, Paradis, Pierre, Lipman, Mark L., Schiffrin, Ernesto L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647261/ https://www.ncbi.nlm.nih.gov/pubmed/23584809 http://dx.doi.org/10.1161/JAHA.113.000128

Ejemplares similares

Human and murine memory γδ T cells: Evidence for acquired immune memory in bacterial and viral infections and autoimmunity
por: Comeau, Kevin, et al.
Publicado: (2020)

CD4(+) Regulatory T Lymphocytes Prevent Impaired Cerebral Blood Flow in Angiotensin II‐Induced Hypertension
por: Iulita, M. Florencia, et al.
Publicado: (2018)

P2X7 Receptors: An Untapped Target for the Management of Cardiovascular Disease
por: Shokoples, Brandon G., et al.
Publicado: (2020)

Determination of Interleukin-17A and Interferon-γ Production in γδ, CD4(+), and CD8(+) T Cells Isolated from Murine Lymphoid Organs, Perivascular Adipose Tissue, Kidney, and Lung
por: Comeau, Kevin, et al.
Publicado: (2023)

Aldosterone, Inflammation, Immune System, and Hypertension
por: Ferreira, Nathanne S, et al.
Publicado: (2020)

Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity
por: Saeidi, R, et al.
Publicado: (2012)

High Systolic Blood Pressure at Hospital Admission Is an Important Risk Factor in Models Predicting Outcome of COVID-19 Patients
por: Caillon, Antoine, et al.
Publicado: (2021)

The Clinical Impact of Recombinant Human Erythropoietin
por: Muirhead, N
Publicado: (1997)

Role of monocytes/macrophages in renin-angiotensin system-induced hypertension and end organ damage
por: Barhoumi, Tlili, et al.
Publicado: (2023)

The relationship between proton pump inhibitor use and serum magnesium concentration among hemodialysis patients: a cross-sectional study
por: Misra, Paraish S., et al.
Publicado: (2015)

Recombinant Erythropoietin in Humans Has a Prolonged Effect on Circulating Erythropoietin Isoform Distribution
por: Aachmann-Andersen, Niels Jacob, et al.
Publicado: (2014)

Induction of erythroferrone in healthy humans by micro-dose recombinant erythropoietin or high-altitude exposure
por: Robach, Paul, et al.
Publicado: (2020)

Pharmacokinetics of PEGylated Recombinant Human Erythropoietin in Rats
por: Cao, Xiaohan, et al.
Publicado: (2014)

Preoperative recombinant human erythropoietin in anemic surgical patients
por: Monk, Terri G
Publicado: (2004)

Recombinant human erythropoietin therapy in critically ill patients
por: Georgopoulos, D, et al.
Publicado: (2005)

Acquired Pure Red Cell Aplasia and Recombinant Erythropoietin
por: Padhi, Somanath, et al.
Publicado: (2021)

Modified recombinant human erythropoietin with potentially reduced immunogenicity
por: Susantad, Thanutsorn, et al.
Publicado: (2021)

Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia.
por: Barosi, G., et al.
Publicado: (1998)

Circulatory therapeutics: use of antihypertensive agents and their effects on the vasculature
por: Schiffrin, Ernesto L
Publicado: (2010)

Estimating Is Not Measuring: The Lessons About Estimated Pulse Wave Velocity
por: Boutouyrie, Pierre
Publicado: (2022)

Reversal of Arterial Stiffness and Maladaptative Arterial Remodeling After Kidney Transplantation
por: Karras, Alexandre, et al.
Publicado: (2017)

Trends in the Treatment of Anemia Using Recombinant Human Erythropoietin in Patients with HIV Infection
por: Sullivan, Patrick S, et al.
Publicado: (2011)

Recombinant human erythropoietin for treating severe traumatic brain injury
por: Bai, Xiao-Fei, et al.
Publicado: (2018)

Modified aptamers as reagents to characterize recombinant human erythropoietin products
por: Jankowski, Wojciech, et al.
Publicado: (2020)

Cross-platform transcriptomic profiling of the response to recombinant human erythropoietin
por: Wang, Guan, et al.
Publicado: (2021)

A gene responsible for prolyl-hydroxylation of moss-produced recombinant human erythropoietin
por: Parsons, Juliana, et al.
Publicado: (2013)

Recombinant human erythropoietin α modulates the effects of radiotherapy on colorectal cancer microvessels
por: Ceelen, W, et al.
Publicado: (2007)

Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis
por: Hardee, M E, et al.
Publicado: (2005)

Trends in Use, Cost, and Outcomes of Human Recombinant Erythropoietin, 1989-98
por: Greer, Joel W., et al.
Publicado: (1999)

Cytoprotective Effect of Recombinant Human Erythropoietin Produced in Transgenic Tobacco Plants
por: Kittur, Farooqahmed S., et al.
Publicado: (2013)

Recombinant human erythropoietin improves neurological outcomes in very preterm infants
por: Song, Juan, et al.
Publicado: (2016)

Transcriptomic Markers of Recombinant Human Erythropoietin Micro-Dosing in Thoroughbred Horses
por: Dahlgren, Anna R., et al.
Publicado: (2021)

Classical and Counter-Regulatory Renin–Angiotensin System: Potential Key Roles in COVID-19 Pathophysiology
por: Almutlaq, Moudhi, et al.
Publicado: (2021)

Reduction of C-reactive protein and the use of anti-hypertensives
por: Savoia, Carmine, et al.
Publicado: (2007)

Arterial Stiffness and Hypertension in the Elderly
por: Laurent, Stéphane, et al.
Publicado: (2020)

Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration
por: Wang, Guan, et al.
Publicado: (2017)

Current Evidence on the Protective Effects of Recombinant Human Erythropoietin and Its Molecular Variants against Pathological Hallmarks of Alzheimer’s Disease
por: Jarero-Basulto, José J., et al.
Publicado: (2020)

Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastoma
por: Ribatti, D, et al.
Publicado: (2007)

Expression and analysis of the glycosylation properties of recombinant human erythropoietin expressed in Pichia pastoris
por: Teh, Ser Huy, et al.
Publicado: (2011)

Effects of Recombinant Human Erythropoietin on Revascularization of Full Thickness Skin Grafts in Rat
por: Fatemi, Mohammad Javad, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4t0rjh4vakbfmog2geu2s4is32